(Q42443730)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

8 March 2020

main subject

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Sezai Sahmay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Nil Atakul

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Yavuz Aydin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Metehan Imamoglu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hakan Seyisoglu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

15 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

Acta Obstetricia et Gynecologica Scandinavica

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1369-1374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Which hormone tests for the diagnosis of polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Serum anti-müllerian hormone concentrations in reproductive age women with and without polycystic ovary syndrome: the influence of body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Serum anti-Müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12247

21 January 2018

Identifiers

DOI

10.1111/AOGS.12247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23980726%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference